Upregulation of secreted aspartyl proteinase genes of fluconazole-sensitive Candida albicans isolates
- 10 October 2019
- journal article
- research article
- Published by Springer Nature in Molecular Biology Reports
- Vol. 46 (6) , 6147-6154
Abstract
Candida albicans infection development depends on several factors associated with this etiological agent, including secreted aspartyl protease (Sap) production. Sap expression commonly occurs under selective pressure caused by the presence of antifungals. Fluconazole is the main antifungal drug used for treatment or prophylaxis. This study investigated the influence of inhibitory and sub-inhibitory fluconazole concentrations on Sap activity and their gene transcription for three clinical C. albicans isolates. Two isolates presented significant increases in Sap activity and transcription of SAP 1-8 genes in the presence of 1 MIC80 of fluconazole compared to the absence of the antifungal agent. The results suggest that the increase in Sap activity occurs due to an upregulation of the SAP gene transcription influenced by fluconazole. This suggests the importance of all SAP genes in the progression of bloodstream infections compared to primary tissue infection. However, this phenomenon does not occur everywhere, and it is multifactorial. This may be related to the selective pressure effect on transcription modulators. Although preliminary, these results open a new perspective for the study of virulence factors.Keywords
This publication has 48 references indexed in Scilit:
- Emerging and Emerged Pathogenic Candida Species: Beyond the Candida albicans ParadigmPLOS Pathogens, 2013
- Candida albicanspathogenicity mechanismsVirulence, 2013
- Amphotericin B resistance leads to enhanced proteinase and phospholipase activity and reduced germ tube formation in Candida albicansFungal Biology, 2009
- Impact of Antifungal Prophylaxis on Colonization and Azole Susceptibility of Candida SpeciesAntimicrobial Agents and Chemotherapy, 2009
- In Vitro Activities of Fluconazole and Voriconazole against Clinical Isolates of Candida spp. Determined by Disk Diffusion Testing in Turin, ItalyAntimicrobial Agents and Chemotherapy, 2009
- Early diagnosis of fungal infection in immunocompromised patientsJournal of Antimicrobial Chemotherapy, 2008
- The Role of Secreted Aspartyl Proteinases inCandida albicansKeratitisInvestigative Ophthalmology & Visual Science, 2007
- Comparison of phospholipase and proteinase activity in Candida albicans and C. dubliniensisMycoses, 2005
- Influence of fluconazole at subinhibitory concentrations on cell surface hydrophobicity and phagocytosis ofCandida albicansFEMS Microbiology Letters, 2000
- Candida albicans: a review of its history, taxonomy, epidemiology, virulence attributes, and methods of strain differentiationInternational Journal of Oral and Maxillofacial Surgery, 1996